Bio Statements
BI
Bio Income Statement
B
M
PLN (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
56.857
100
40.686
71.6
16.171
28.4
—
0
6.666
11.7
16.054
28.2
0.117
0.2
-0.555
-1
-0.478
-0.8
-0.937
-1.6
-0.005
-0.009
-0.932
-1.6
-0.311
3
60.741
100
43.827
72.2
16.914
27.8
—
0
6.772
11.1
16.763
27.6
0.151
0.2
-0.722
-1.2
0.869
1.4
0.446
0.7
0.053
0.09
0.394
0.6
0.131
3
68.968
100
50.316
73
18.652
27
—
0
6.78
9.8
16.526
24
2.126
3.1
-0.471
-0.7
0.094
0.1
1.678
2.4
0.387
0.6
1.291
1.9
0.43
3
52.981
100
39.275
74.1
13.706
25.9
—
0
5.45
10.3
13.971
26.4
-0.265
-0.5
-0.525
-1
0.556
1
-0.272
-0.5
-0.137
-0.3
-0.135
-0.3
-0.061
2.2
45.479
100
33.364
73.4
12.115
26.6
—
0
5.24
11.5
12.507
27.5
-0.392
-0.9
-0.457
-1.005
-0.511
-1.1
-1.221
-2.7
-0.106
-0.2
-1.114
-2.4
-0.371
3
46.734
100
33.871
72.5
12.863
27.5
—
0
5.297
11.3
12.424
26.6
0.439
0.9
-0.342
-0.7
-0.057
-0.1
-0.053
-0.1
0.082
0.2
-0.135
-0.3
-0.045
3
56.271
100
40.577
72.1
15.694
27.9
—
0
5.639
10
12.838
22.8
2.856
5.1
-0.257
-0.5
-0.139
-0.2
2.456
4.4
0.49
0.9
1.966
3.5
0.655
3
54.01
100
40.125
74.3
13.885
25.7
—
0
6.117
11.3
13.648
25.3
0.237
0.4
-0.196
-0.4
0.044
0.08
0.039
0.07
0.298
0.6
-0.261
-0.5
-0.093
2.8
43.629
100
32.068
73.5
11.561
26.5
—
0
5.028
11.5
11.285
25.9
0.276
0.6
-0.215
-0.5
-0.259
-0.6
-0.157
-0.4
-0.321
-0.7
0.165
0.4
0.059
2.8
107.81
100
77.895
72.3
29.914
27.7
—
0
10.802
10
25.241
23.4
4.673
4.3
-0.149
-0.1
0.118
0.1
4.654
4.3
0.948
0.9
3.706
3.4
1.324
2.8
58.938
100
42.404
71.9
16.534
28.1
—
0
5.567
9.4
12.608
21.4
3.926
6.7
-0.07
-0.1
-0.229
-0.4
3.613
6.1
0.75
1.3
2.863
4.9
1.022
2.8